<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical significance of isolated IgE deficiency</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical significance of isolated IgE deficiency</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical significance of isolated IgE deficiency</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John Kelly Smith, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guha Krishnaswamy, MD, FACP, FCCP, FACAAI, FAAAI, CC-D</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jordan S Orange, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION AND DEFINITION</span><span class="headingEndMark"> — </span>Selective immunoglobulin (Ig)E deficiency is defined as a significant decrease in the levels of IgE (&lt;2.5 international units/mL) in a patient whose other immunoglobulin levels, including IgG, IgG subclasses, and IgA levels, are normal. It is a laboratory finding that does not necessarily equate to a clinical disorder, and selective IgE deficiency has not been included in international classification systems for primary immunodeficiency diseases [<a href="#rid1">1</a>]. </p><p>This topic review will present the information available about this subject.</p><p class="bulletIndent1"><span class="glyph">●</span>The normal production of IgE and the disorders associated with elevated IgE levels are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5542.html" rel="external">"The biology of IgE"</a> and  <a class="medical medical_review" href="/z/d/html/3975.html" rel="external">"The adaptive humoral immune response"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The role of IgE in the pathogenesis of allergic disease has been extensively studied and is reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/83038.html" rel="external">"The relationship between IgE and allergic disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anti-IgE therapy for the treatment of asthma and allergic disease is discussed elsewhere. Of note, anti-IgE therapy reduces serum levels of free IgE but elevates serum levels of total IgE, so it induces a state that is distinct from IgE deficiency [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/545.html" rel="external">"Anti-IgE therapy"</a>.) </p><p></p><p class="headingAnchor" id="H1776682356"><span class="h1">MEASUREMENT OF IgE</span><span class="headingEndMark"> — </span>Accurate IgE levels may be obtained with the type of testing routinely performed by commercial laboratories. This usually involves a paper radioimmunosorbent test (PRIST) to measure total serum IgE. The detection range of this test is 0.5 to 800 kU/L. A level below 2.5 kU/L is considered deficient.</p><p class="headingAnchor" id="H2"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>The prevalence of isolated IgE deficiency depends upon the population under study. The authors measured serum IgE levels in 500 blood donors, 974 allergy/immunology clinic patients, and 155 rheumatology clinic patients and found deficient levels in 2.6, 8.1, and 9.7 percent, respectively [<a href="#rid3">3</a>]. IgE deficiency was selective (ie, other immunoglobulin classes were normal) in 0.8, 3.1, and 1.3 percent, respectively, of these cohorts. Associated immunoglobulin deficiencies varied among the three populations (<a class="graphic graphic_table graphicRef65822" href="/z/d/graphic/65822.html" rel="external">table 1</a>) [<a href="#rid3">3</a>]. Three additional studies involving a total of 8280 patients found isolated IgE deficiencies in 2.4 percent of subjects (range 1 to 2.6 percent) [<a href="#rid4">4-6</a>]. </p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of a selectively low level of IgE deficiency is unclear. Defects in immunoglobulin class-switching have not been conclusively demonstrated [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H504330469"><span class="h1">ASSOCIATED DISORDERS</span><span class="headingEndMark"> — </span>Information on disorders possibly associated with selective IgE deficiency is based upon a small number of studies, including a case-control study of 226 children and adults in a health care system and a retrospective review of 44 patients referred to the authors' allergy/immunology practice [<a href="#rid3">3,7</a>]. IgE deficiency may be associated with increased susceptibility to certain infections, sinopulmonary disease, nonallergic airway disease, immunodeficiency, autoimmunity, and malignancy.</p><p class="headingAnchor" id="H6"><span class="h2">Infections</span><span class="headingEndMark"> — </span>There is some evidence that IgE antibodies play a protective role against viral and parasitic infections in humans [<a href="#rid3">3,7-17</a>]. However, due in part to the redundancy of the immune system, low or absent levels of IgE do not predispose people to severe parasitic infections [<a href="#rid18">18</a>]. IgE does not participate in the opsonization of bacteria, but it may play a role in mucosal defense against bacterial infections in other ways. IgE is predominantly a mucosal immunoglobulin. A potential association between IgE deficiency and increased sinopulmonary infections was noted in the two largest studies:</p><p class="bulletIndent1"><span class="glyph">●</span>In the authors' study, patients with selective IgE deficiency sought medical advice in the allergy/immunology clinic because of persistent sinopulmonary symptoms that were assumed by the patients to be allergic in origin, but sensitization to allergens was not found [<a href="#rid3">3</a>]. There was an increased prevalence of infections with common bacteria, including <em>Streptococcus pneumoniae</em>, <em>Hemophilus influenzae</em>, and <em>Moraxella catarrhalis. </em>A similar association was found in a study of 130 patients with isolated IgE deficiency [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In children, IgE antibodies have been shown to provide some protection against Lyme disease (<em>Borrelia burgdorferi </em>infection), which persists throughout adulthood [<a href="#rid11">11</a>]. The prevalence of gastric infection with <em>Helicobacter pylori</em> has been reported to be significantly higher in dyspeptic patients with selective IgE deficiency as compared with dyspeptic patients with normal IgE levels [<a href="#rid17">17</a>].</p><p></p><p class="headingAnchor" id="H3799160627"><span class="h3">Sinopulmonary disease</span><span class="headingEndMark"> — </span>Several reports have documented a higher incidence of rhinitis, rhinosinusitis, and/or bronchitis in patients with selective IgE deficiency [<a href="#rid3">3,7,14,15</a>]. However, other groups have not found this association [<a href="#rid16">16</a>].</p><p>In the large case-control study of 226 patients with selective IgE deficiency mentioned earlier, there was a significantly higher prevalence of chronic rhinosinusitis and otitis media in both children and adults when compared with age-matched controls [<a href="#rid7">7</a>]. In the same cohort, the prevalence of gastric infection with <em>H. pylori</em> was significantly higher in dyspeptic patients with selective IgE deficiency (&lt;2 kIU/mL) compared with dyspeptic patients with normal IgE levels [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Nonallergic airway disease</span><span class="headingEndMark"> — </span>The authors reported a higher prevalence of nonallergic reactive airway disease in patients with selective IgE deficiency (&lt;2.5 kIU/mL) compared with age- and sex-matched controls [<a href="#rid3">3</a>]. Other groups reported similar findings (&lt;2 kIU/mL) [<a href="#rid7">7</a>].</p><p>The possibility that IgE may play a role in the regulation of the respiratory immune response is suggested by several studies in experimental animal models. Mice that are deficient in lymphotoxin alpha (LTalpha -/- mice) also exhibit diminished levels of IgE and reduced allergic airway responsiveness to both environmental and induced antigen challenge [<a href="#rid19">19</a>]. These mice develop inflammatory airway disease that is nonallergic and noninfectious and mediated by T helper type 1 (Th1) cells. The lung inflammation is alleviated by reconstitution of IgE. Furthermore, depletion of IgE in wild-type mice duplicates the lung pathologies of the LTalpha -/- mice and is also reversed by the administration of IgE.</p><p>These findings are consistent with the theory that the presence of subnormal levels of IgE impairs the ability of mast cells to respond normally to airway antigens and consequently, to produce cytokines that favor T helper type 2 (Th2) development (interleukin [IL]-4, IL-13). As a result, Th1 responses to the uncleared antigens predominate and lead to pathology.</p><p>Rather than merely priming mast cells to respond to specific antigens, IgE (in the absence of cross-linking antigens) may promote survival, receptor expression, and mediator release of mast cells and promote a healthy balance between Th1 and Th2 processes responses [<a href="#rid20">20-24</a>].</p><p class="headingAnchor" id="H3474842034"><span class="h2">Immunodeficiencies</span><span class="headingEndMark"> — </span>Low serum levels of IgE can accompany several well-defined immunodeficiency diseases, including common variable immunodeficiency (CVID), IgG subclass deficiencies, selective IgA deficiency, ataxia-telangiectasia, and agammaglobulinemia [<a href="#rid3">3,25,26</a>]. Most patients with CVID have very low levels of IgE, but the diagnosis also requires low IgG, plus low IgA or IgM. (See  <a class="medical medical_review" href="/z/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults", section on 'Immunoglobulin levels'</a> and  <a class="medical medical_review" href="/z/d/html/3906.html" rel="external">"IgG subclass deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/6233.html" rel="external">"Ataxia-telangiectasia"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Autoimmune disease</span><span class="headingEndMark"> — </span>There is an increased prevalence of autoimmune disease in persons with certain immunoglobulin deficiencies, particularly those with IgA deficiency, and the two largest studies of patients with selective IgE deficiency found a similar association [<a href="#rid3">3,7</a>]. Several other reports have documented a similar association of selective IgE deficiency and autoimmunity [<a href="#rid6">6,17</a>].</p><p>There are a number of potential mechanisms that could explain this finding [<a href="#rid27">27-33</a>]. Because IgE is predominantly a mucosal immunoglobulin, it may protect against autoimmunization by preventing the systemic absorption of mucosal antigens, similar to the proposed function of IgA [<a href="#rid34">34</a>]. Defective antigen exclusion at the mucosal barrier could allow exogenous antigens to induce autoimmune responses by:</p><p class="bulletIndent1"><span class="glyph">●</span>Stimulating autoreactive lymphocytes through molecular mimicry [<a href="#rid27">27</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Promoting immune complex formation [<a href="#rid28">28</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Super antigen-induced polyclonal activation of lymphocytes [<a href="#rid29">29</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Inducing a perturbation of the idiotypic network [<a href="#rid30">30</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Aberrant induction of major histocompatibility complex class II antigens [<a href="#rid31">31</a>]</p><p></p><p>If IgE promotes mast cell survival, receptor expression, and mediator release, it may also facilitate immune responses [<a href="#rid20">20</a>]. It is possible that IgE deficiency predisposes to autoimmunity by adversely effecting mast cell survival and function. In a mouse model, mast cells were shown to be essential intermediaries in regulatory T cell (Treg)-induced allograft tolerance [<a href="#rid32">32</a>].</p><p>Alternative hypotheses include:</p><p class="bulletIndent1"><span class="glyph">●</span>Common genetic factors predispose to both IgE deficiency and autoimmune disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low levels of IgE merely reflect an imbalance between Th1 and Th2 lymphocyte activity that, in turn, favors the development of Th1-mediated autoimmune diseases [<a href="#rid32">32</a>].</p><p></p><p class="headingAnchor" id="H3816505610"><span class="h2">Antitumor activity</span><span class="headingEndMark"> — </span>IgE has been shown to possess antitumor properties in vitro [<a href="#rid35">35,36</a>] and in experimental mice [<a href="#rid37">37-40</a>]. IgE has been shown to play an active role in tumor immunosurveillance in mice [<a href="#rid41">41</a>] and to induce human colon cancer cell apoptosis in vitro by enhancing cyp27b1 expression [<a href="#rid42">42</a>].</p><p>A large survey cohort study found that the incidence of prior malignancy was higher in persons with selective IgE deficiency as compared with those with normal IgE levels [<a href="#rid43">43</a>]. A similar observation was made in patients with CVID, with and without IgE deficiency [<a href="#rid5">5</a>]. The same researchers performed a longitudinal cohort study of 42 patients with IgE deficiency (one of whom had CVID), who were matched to patients with normal, high, or very high (≥1000 kIU/mL) IgE levels and prospectively followed for a median of 44 months [<a href="#rid44">44</a>]. The rate of newly diagnosed malignancy was significantly higher in the IgE-deficient group compared with patients without IgE deficiency (all other groups combined) (17.6 versus 3.8 percent) (odds ratio [OR] 5.4, 95% CI 1.3-22.9), although not when only compared to patients with normal levels. The types of malignancies included both hematologic and solid tumors. Although these data are not sufficient to understand any relationships that underlie an association with possible increased malignancy risk, potential explanations include that IgE itself has antitumor activity in humans, that IgE is being sequestered by malignant tissue, or that low IgE is an epiphenomenon of immune dysregulation. Larger prospective studies including longer periods of observation are needed.</p><p>Until more information is available, patients with isolated IgE deficiency should be advised to stay current with routine health maintenance, adhere to recommendations for exercise, diet, and weight control, stop smoking, and obtain age- and sex-appropriate cancer screening tests. (See  <a class="medical medical_review" href="/z/d/html/97819.html" rel="external">"Overview of preventive care in adults", section on 'Cancer prevention'</a> and  <a class="medical medical_review" href="/z/d/html/97819.html" rel="external">"Overview of preventive care in adults", section on 'Cancer screening'</a>.)</p><p class="headingAnchor" id="H3566897707"><span class="h1">ASSOCIATED CLINICAL AND LABORATORY FEATURES</span><span class="headingEndMark"> — </span>Most patients are identified when immunoglobulin analysis includes an IgE determination. Abnormally high or low levels should be verified by repeat testing. No further work-up is available or necessary to define a low IgE level. As noted above:</p><p class="bulletIndent1"><span class="glyph">●</span>IgE deficiency has been associated with other immunodeficiencies, rhinosinusitis, other respiratory ailments, and autoimmune disease. These should be evaluated as needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the authors' allergy/immunology clinic, the majority of 30 patients with selective IgE deficiency sought medical advice because of persistent sinopulmonary symptoms that were assumed by the patients to be allergic in origin but were found on skin or radioallergosorbent testing (RAST) to be nonallergic in origin [<a href="#rid3">3</a>]. Airway symptoms included sinus pain and congestion, nasal congestion and rhinorrhea, persistent or intermittent cough, and wheezing. Sinopulmonary infections, documented by culture, were more prevalent in patients with selective IgE deficiency than in those with normal IgE levels. These infections were less severe than those occurring in patients with IgE coupled with other immunoglobulin deficiencies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Data on vaccine responses in patients with selective IgE deficiency are lacking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In addition to nonallergic reactive airway disease, IgE-deficient patients were more likely to have one or more autoimmune diseases and to complain of arthralgias, chronic fatigue, and symptoms suggestive of airway infection (purulent sputum and/or nasal discharge) when compared to a sex- and age-matched control group from the same clinic with normal levels of IgE.</p><p></p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Selective immunoglobulin (Ig)E deficiency is defined as a significant decrease in the levels of IgE (&lt;2.5 international units/mL) in a patient whose other immunoglobulin levels, including IgA, IgG, and IgG subclasses, are normal. It is a laboratory finding that has not been demonstrated to equate to a clinical disorder, and selective IgE deficiency is not considered to be a primary immunodeficiency. (See <a class="local">'Introduction and definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence of selective IgE deficiency is highly dependent on the population under study and can range from as low as 0.8 percent in blood donors to as high as 3.1 percent in rheumatology patients, with an overall prevalence of 2.4 percent. IgE deficiency can occur in isolation or in combination with other immunoglobulin deficiencies. (See <a class="local">'Prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgE-deficient patients can present with symptoms of reactive airway disease (rhinosinusitis, bronchitis, asthma), sinopulmonary infection, chronic fatigue, arthralgias, and serologic or clinical evidence of autoimmune disease. An association between very low serum IgE and malignancy has been noted in some studies. (See <a class="local">'Associated disorders'</a> above.)</p><p></p><p class="headingAnchor" id="H3568040515"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges E Richard Stiehm, MD, who contributed as a Section Editor to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42:1473.</a></li><li><a class="nounderline abstract_t">Çildağ S, Şentürk T. The effect of omalizumab treatment on IgE and other immunoglobulin levels in patients with chronic spontaneous urticaria and its association with treatment response. Postepy Dermatol Alergol 2018; 35:516.</a></li><li><a class="nounderline abstract_t">Smith JK, Krishnaswamy GH, Dykes R, et al. Clinical manifestations of IgE hypogammaglobulinemia. Ann Allergy Asthma Immunol 1997; 78:313.</a></li><li><a class="nounderline abstract_t">Roa S, Isidoro-Garcia M, Davila I, et al. Molecular analysis of activation-induced cytidine deaminase gene in immunoglobulin-E deficient patients. Clin Dev Immunol 2008; 2008:146715.</a></li><li><a class="nounderline abstract_t">Ferastraoaru D, Gross R, Rosenstreich D. Increased malignancy incidence in IgE deficient patients not due to concomitant Common Variable Immunodeficiency. Ann Allergy Asthma Immunol 2017; 119:267.</a></li><li><a class="nounderline abstract_t">Kazmirchuk VIe, Tsaryk VV, Sydorenko OI, et al. [FREQUENCY OF IMMUNOGLOBULIN E DEFICIENCY AMONG PATIENTS WITH IMMUNODEPENDENT DISORDERS]. Lik Sprava 2014; :3.</a></li><li><a class="nounderline abstract_t">Magen E, Schlesinger M, David M, et al. Selective IgE deficiency, immune dysregulation, and autoimmunity. Allergy Asthma Proc 2014; 35:e27.</a></li><li><a class="nounderline abstract_t">Pellegrino MG, Bluth MH, Smith-Norowitz T, et al. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro. AIDS Res Hum Retroviruses 2002; 18:363.</a></li><li><a class="nounderline abstract_t">Bereczky S, Montgomery SM, Troye-Blomberg M, et al. Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria. Int J Parasitol 2004; 34:935.</a></li><li><a class="nounderline abstract_t">Duarte J, Deshpande P, Guiyedi V, et al. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Malar J 2007; 6:1.</a></li><li><a class="nounderline abstract_t">Bluth MH, Robin J, Ruditsky M, et al. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease. Scand J Immunol 2007; 65:376.</a></li><li><a class="nounderline abstract_t">Bluth MH, Norowitz KB, Chice S, et al. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency. Hum Immunol 2005; 66:1029.</a></li><li><a class="nounderline abstract_t">Hagel I, Lynch NR, Di Prisco MC, et al. Ascaris reinfection of slum children: relation with the IgE response. Clin Exp Immunol 1993; 94:80.</a></li><li><a class="nounderline abstract_t">Cain WA, Ammann AJ, Hong R, et al. IgE deficiency associated with chronic sinopulmonary infection. J Clin Invest 1969; 48:12a (Abstract).</a></li><li><a class="nounderline abstract_t">Schoettler JJ, Schleissner LA, Heiner DC. Familial IgE deficiency associated with sinopulmonary disease. Chest 1989; 96:516.</a></li><li><a class="nounderline abstract_t">Levin TA, Ownby DR, Smith PH, et al. Relationship between extremely low total serum IgE levels and rhinosinusitis. Ann Allergy Asthma Immunol 2006; 97:650.</a></li><li><a class="nounderline abstract_t">Magen E, Schlesinger M, Ben-Zion I, Vardy D. Helicobacter pylori infection in patients with selective immunoglobulin E deficiency. World J Gastroenterol 2015; 21:240.</a></li><li><a class="nounderline abstract_t">Watanabe N, Katakura K, Kobayashi A, et al. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis. Proc Natl Acad Sci U S A 1988; 85:4460.</a></li><li><a class="nounderline abstract_t">Kang HS, Blink SE, Chin RK, et al. Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation. J Exp Med 2003; 198:1643.</a></li><li><a class="nounderline abstract_t">Kitaura J, Song J, Tsai M, et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci U S A 2003; 100:12911.</a></li><li><a class="nounderline abstract_t">Lam V, Kalesnikoff J, Lee CW, et al. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood 2003; 102:1405.</a></li><li><a class="nounderline abstract_t">Kawakami T, Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 2005; 175:4167.</a></li><li><a class="nounderline abstract_t">Kumar V, Sharma A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Mol Immunol 2010; 48:14.</a></li><li><a class="nounderline abstract_t">Kashiwakura J, Xiao W, Kitaura J, et al. Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype. J Leukoc Biol 2008; 84:357.</a></li><li><a class="nounderline abstract_t">Polmar SH, Waldmann TA, Balestra ST, et al. Immunoglobulin E in immunologic deficiency diseases. I. Relation of IgE and IgA to respiratory tract disease in isolated IgE deficiency, IgA deficiency, and ataxia telangiectasia. J Clin Invest 1972; 51:326.</a></li><li><a class="nounderline abstract_t">Waldmann TA, Polmar SH, Balestra ST, et al. Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome. J Immunol 1972; 109:304.</a></li><li class="breakAll">Oldstone MBA. Molecular mimicry: Cross-reactivity between microbes and host proteins as a cause of autoimmunity, Springer-Verlag, New York 1989. p.1.</li><li><a class="nounderline abstract_t">Cunningham-Rundles C, Brandeis WE, Pudifin DJ, et al. Autoimmunity in selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune complexes and clinical disease. Clin Exp Immunol 1981; 45:299.</a></li><li><a class="nounderline abstract_t">Paliard X, West SG, Lafferty JA, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253:325.</a></li><li><a class="nounderline abstract_t">Cooke A, Lydyard PM, Roitt IM. Mechanisms of autoimmunity: a role for cross-reactive idiotypes. Immunol Today 1983; 4:170.</a></li><li><a class="nounderline abstract_t">Sarvetnick N, Liggitt D, Pitts SL, et al. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52:773.</a></li><li><a class="nounderline abstract_t">Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442:997.</a></li><li><a class="nounderline abstract_t">Chan RW, Lai FM, Li EK, et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology (Oxford) 2006; 45:951.</a></li><li><a class="nounderline abstract_t">Liblau RS, Bach JF. Selective IgA deficiency and autoimmunity. Int Arch Allergy Immunol 1992; 99:16.</a></li><li><a class="nounderline abstract_t">Fu SL, Pierre J, Smith-Norowitz TA, et al. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008; 153:401.</a></li><li><a class="nounderline abstract_t">Reali E, Greiner JW, Corti A, et al. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. Cancer Res 2001; 61:5517.</a></li><li><a class="nounderline abstract_t">Nigro EA, Brini AT, Soprana E, et al. Antitumor IgE adjuvanticity: key role of Fc epsilon RI. J Immunol 2009; 183:4530.</a></li><li><a class="nounderline abstract_t">Daniels-Wells TR, Helguera G, Leuchter RK, et al. A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy. BMC Cancer 2013; 13:195.</a></li><li><a class="nounderline abstract_t">Karagiannis SN, Wang Q, East N, et al. Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol 2003; 33:1030.</a></li><li><a class="nounderline abstract_t">Nagy E, Berczi I, Sehon AH. Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus. Cancer Immunol Immunother 1991; 34:63.</a></li><li><a class="nounderline abstract_t">Nigro EA, Brini AT, Yenagi VA, et al. Cutting Edge: IgE Plays an Active Role in Tumor Immunosurveillance in Mice. J Immunol 2016; 197:2583.</a></li><li><a class="nounderline abstract_t">Ye ZS, Fan LN, Wang L, et al. Immunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression. Am J Transl Res 2016; 8:5715.</a></li><li><a class="nounderline abstract_t">Ferastraoaru D, Rosenstreich D. IgE deficiency and prior diagnosis of malignancy: Results of the 2005-2006 National Health and Nutrition Examination Survey. Ann Allergy Asthma Immunol 2018; 121:613.</a></li><li><a class="nounderline abstract_t">Ferastraoaru D, Rosenstreich D. IgE deficiency is associated with high rates of new malignancies: Results of a longitudinal cohort study. J Allergy Clin Immunol Pract 2020; 8:413.</a></li></ol></div><div id="topicVersionRevision">Topic 3947 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35748970" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30429712" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The effect of omalizumab treatment on IgE and other immunoglobulin levels in patients with chronic spontaneous urticaria and its association with treatment response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9087159" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical manifestations of IgE hypogammaglobulinemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19266080" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Molecular analysis of activation-induced cytidine deaminase gene in immunoglobulin-E deficient patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28778662" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Increased malignancy incidence in IgE deficient patients not due to concomitant Common Variable Immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26118074" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : [FREQUENCY OF IMMUNOGLOBULIN E DEFICIENCY AMONG PATIENTS WITH IMMUNODEPENDENT DISORDERS].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24717782" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Selective IgE deficiency, immune dysregulation, and autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11897038" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15217732" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17204149" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17386029" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16386644" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8403522" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Ascaris reinfection of slum children: relation with the IgE response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : IgE deficiency associated with chronic sinopulmonary infection</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2766811" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Familial IgE deficiency associated with sinopulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17165274" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Relationship between extremely low total serum IgE levels and rhinosinusitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25574097" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Helicobacter pylori infection in patients with selective immunoglobulin E deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3380800" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14638845" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14569021" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12702510" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16177053" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20678798" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Mast cells: emerging sentinel innate immune cells with diverse role in immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18477690" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5009116" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Immunoglobulin E in immunologic deficiency diseases. I. Relation of IgE and IgA to respiratory tract disease in isolated IgE deficiency, IgA deficiency, and ataxia telangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5047372" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5047372" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7318256" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Autoimmunity in selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune complexes and clinical disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1857971" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Evidence for the effects of a superantigen in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25289538" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mechanisms of autoimmunity: a role for cross-reactive idiotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2449974" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16921386" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Mast cells are essential intermediaries in regulatory T-cell tolerance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16461436" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1483063" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Selective IgA deficiency and autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18803764" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11454701" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19748979" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Antitumor IgE adjuvanticity: key role of Fc epsilon RI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23594731" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12672069" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1662114" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27566822" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Cutting Edge: IgE Plays an Active Role in Tumor Immunosurveillance in Mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28078042" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Immunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30086407" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : IgE deficiency and prior diagnosis of malignancy: Results of the 2005-2006 National Health and Nutrition Examination Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31295561" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : IgE deficiency is associated with high rates of new malignancies: Results of a longitudinal cohort study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
